Hologic, Inc. (HOLX) P/E Ratio History
Historical price-to-earnings valuation from 1992 to 2026
Loading P/E history...
HOLX Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Hologic, Inc. (HOLX) trades at a price-to-earnings ratio of 30.5x, with a stock price of $76.01 and trailing twelve-month earnings per share of $2.41.
The current P/E is 33% above its 5-year average of 23.0x. Over the past five years, HOLX's P/E has ranged from a low of 8.4x to a high of 42.0x, placing the current valuation at the 75th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.2x, HOLX trades at a 38% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 171.0x.
Relative to the broader market, HOLX commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HOLX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
HOLX P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $52B | 24.7Lowest | 1.49Best | -1% | |
| $45B | 43.0 | 3.01 | +23% | |
| $23B | 28.5 | 2.72 | +47%Best | |
| $160B | 57.4 | 2.64 | +23% | |
| $7B | 89.5 | - | -76% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
HOLX Historical P/E Data (1992–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | Sat Dec 27 2025 00:00:00 GM | $74.50 | $2.40 | 31.0x | -37% |
| FY2025 Q4 | Sat Sep 27 2025 00:00:00 GM | $67.21 | $2.48 | 27.1x | -45% |
| FY2025 Q3 | Sat Jun 28 2025 00:00:00 GM | $65.01 | $2.41 | 27.0x | -46% |
| FY2025 Q2 | Sat Mar 29 2025 00:00:00 GM | $61.32 | $2.37 | 25.9x | -48% |
| FY2025 Q1 | Sat Dec 28 2024 00:00:00 GM | $72.60 | $3.17 | 22.9x | -54% |
| FY2024 Q4 | Mon Sep 30 2024 00:00:00 GM | $81.46 | $3.33 | 24.5x | -51% |
| FY2024 Q3 | Sat Jun 29 2024 00:00:00 GM | $74.25 | $2.94 | 25.3x | -49% |
| FY2024 Q2 | Sat Mar 30 2024 00:00:00 GM | $77.96 | $1.96 | 39.8x | -20% |
| FY2024 Q1 | Sat Dec 30 2023 00:00:00 GM | $71.45 | $2.11 | 33.9x | -32% |
| FY2023 Q4 | Sat Sep 30 2023 00:00:00 GM | $69.40 | $1.83 | 37.9x | -24% |
| FY2023 Q3 | Sat Jul 01 2023 00:00:00 GM | $80.97 | $1.93 | 42.0x | -15% |
| FY2023 Q2 | Sat Apr 01 2023 00:00:00 GM | $80.70 | $2.99 | 27.0x | -46% |
Average P/E for displayed period: 49.6x
Full HOLX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See HOLX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HOLX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HOLX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHOLX — Frequently Asked Questions
Quick answers to the most common questions about buying HOLX stock.
Is HOLX stock overvalued or undervalued?
HOLX trades at 30.5x P/E, above its 5-year average of 23.0x. The 75th percentile ranking indicates a premium to historical valuation.
How does HOLX's valuation compare to peers?
Hologic, Inc. P/E of 30.5x compares to sector median of 22.2x. The premium reflects expected growth above peers.
What is HOLX's PEG ratio?
HOLX PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1992-2026.